David K. Murdock - Concepedia

Author

David K. Murdock

Also Known As

Charle N Morcos, D K Murdock, D. K. Murdock, D.K Murdock, DAVID K. MURDOCK, DAVID MURDOCK, David K Murdock, David K. Murdock, David Murdock, Murdock, David K

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Loyola University Medical Center Edward Hines, Jr. VA Hospital Aspirus Wausau Hospital Pennsylvania State University Aspirus

About

David K. Murdock is an author at Loyola University Medical Center specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	861
2	Public Health	8	8	314
3	Health Sciences	3	3	136
4	Social Sciences	1	1	15
5	Allergy	1	1	11

David K. Murdock

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
In vivo effects of acute changes in osmolality and sodium concentration on myocardial contractility Greg Kozeny, David K. Murdock, David E. Euler, American Heart Journal Cardiac MuscleCardiomyopathyMyocardial ContractilityCardiovascular DiseasePhysiology	1985	119
Electrophysiology of coronary reperfusion. A mechanism for reperfusion arrhythmias. David K. Murdock, Jennifer M. Loeb, David E. Euler, Circulation	1980	113
Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass Grafting Ronald H. Miles, Rod Passman, David K. Murdock The American Journal of Cardiology ThrombosisCardiovascular DiseaseCardiovascular PharmacologyRanolazine Versus AmiodaronePharmacotherapy	2011	105
Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD Shocks T. Jared Bunch, Srijoy Mahapatra, David K. Murdock, Pacing and Clinical Electrophysiology	2011	100
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. David K. Murdock, Naomi Overton, Mary Kersten, PubMed	2008	83
Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders David K. Murdock, Anthony K. Murdock, Robert Murdock, American Heart Journal ThrombosisMetabolic SyndromeMixed Lipid DisordersHmg-coa Reductase InhibitorsLipid Disorder	1999	76
Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody. M R Costanzo-Nordin, M. A. Silver, J B O'Connell, PubMed Heart FailureImmunologyTransplantation MedicineImmunotherapyTranslational Medicine	1987	64
Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media. Ming H. Hwang, Zhen En Piao, David K. Murdock, Radiology Blood ClotThrombosisVenous ThrombosisContrast MediaHematology	1990	63
The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation Nicholas J. Stamato, John B. O’Connell, David K. Murdock, American Heart Journal Cardiac MuscleCardiomyopathyHeart FailureElectrical StimulationDevice Therapy	1986	60
A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin Donald B. Hunninghake, Mark E. McGovern, Michael J. Koren, Clinical Cardiology	2003	59

Page 1